MedTrace Logo

Nasal Ketamine for Minor Procedures in Children

NCT02839928 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-07-21

No results posted yet for this study

Summary

Nasal Ketamine has previously been tested in children for deep sedation or preoperative anxiolysis. The investigators intend to test the efficacy of low dose nasal Ketamine in children undergoing minor procedures in the emergency department.

Conditions

Interventions

DRUG

Intranasal ketamine

The experimental arm consists of an single intranasal administration of Ketamine (Ketalar).

DEVICE

Intranasal atomizer

Ketamine will be applied to each nare via intranasal atomizer

DRUG

EMLA

Sponsors & Collaborators

  • Kaplan Medical Center

    lead OTHER

Principal Investigators

  • Eric Scheier, MD · Physician, pediatric emergency department

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02839928 on ClinicalTrials.gov